Danone ADR DANOY

$13.80 +0.17 (1.25%)

Valuation

Market cap: 47,150,272,000
Revenue TTM: $30,867,990,000
Net income TTM: $2,063,670,000
PE ratio: 0.00
Forward PE: 15.37
Profit margin: 6.69%
Debt to equity: 0.85

Trading

Volume: 1,773,300
Avg volume: 648,596
Day's range: $13.70 – $13.85
Shares out: 3,416,686,000
Stochastic %K: 95%
Beta: 0.16
Analysts: Sell
Price target: $20.60

Price

Company profile

Danone S.A. operates in the food and beverage industry in Europe, Ukraine, North America, China, North Asia, the Oceania, Latin America, rest of Asia, Africa, Turkey, the Middle East, and the Commonwealth of Independent States. The company operates through Essential Dairy & Plant-Based, Specialized Nutrition, and Waters segments. It produces and distributes yogurts, dairy products, coffee creations and drinks, beverages, plant-based products, ice creams, frozen desserts, and cheese products. The company also provides specialized nutrition, including formulas and complementary feeding for babies and young children; and special medical purposes food for children and adults. In addition, it offers tube feeding products and oral nutritional supplements. Further, the company provides mineral waters from natural sources, waters infused with natural fruit extracts, fruit juices, and vitamins. The company offers its products under the Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, Danone, Oikos, YoPRO, International Delight, SToK, Silk, So Delicious, Cow & Gate, Bebelac, SGM, Dumex, HiQ, Nursie, Phosphatine, Mizone, Blédina, Nutrison, Fortimel, Neocate, Nutridrink, AQUA, Bonafont, Salus, Hayat, Sirma, Font Vella, Lanjarón, and Zywiec Zdroj brands.It distributes its products through retail chains and traditional market outlets; convenience stores; hotels, restaurants, and coffee outlets; hospitals, clinics, and pharmacies; and e-commerce channels. The company was formerly known as Groupe Danone and changed its name to Danone S.A. in April 2009. Danone S.A. was incorporated in 1899 and is headquartered in Paris, France.

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 33 1 44 35 20 20
Website: https://www.danone.com
Address: 59-61 rue La Fayette, Paris, France

Latest news

No headlines yet.

Stocktwits

TradeSquirtle Oct 12, 5:16 PM

$BYND $DANOY Giant shakeout while the big players are preparing for Plant-based 2.0. https://newstree.substack.com/p/the-funeral-for-plant-based-meat

0 replies

Missfortunate Oct 12, 8:40 AM

We already know $BYND is having double digit growth in Europe. $DANOY recently aqcuired HUEL, them acquiring $BYND seems more and more likely!

1 replies

TradeSquirtle Oct 11, 8:22 PM

$BYND Interesting status from one of their most recent hires on Linkedin. Alpro is the plant-based division of $DANOY , France's biggest food company sporting a $42.5B market cap. While they currently operate in different segments of the plant-based market $DANOY has been aggressively expanding this segment via it's M&A roadmap. Their last earnings explicitly stated that 'we'll push our plant-based offering'. Could $BYND be next?

2 replies

topstockalerts Jun 19, 8:08 PM

Barclays believes the recent selloff in European consumer staples has been driven more by valuation compression than earnings deterioration, creating attractive opportunities as earnings downgrades ease and consumer demand shows signs of stabilization. The broker favors companies with resilient earnings and discounted valuations. L’Oréal stands out for its strong profit profile, premium positioning, and long-term exposure to structural beauty market growth. Danone is viewed as one of the clearest re-rating opportunities after a sharp valuation reset despite only modest earnings cuts. Unilever remains attractive thanks to resilient earnings expectations and its diversified global portfolio. Barclays also highlights Carlsberg, whose share price decline appears disconnected from stable earnings estimates, and Pernod Ricard, where much of the negative outlook may already be priced in. $LRLCY $UL $DANOY

0 replies

topstockalerts May 19, 11:41 PM

Nestlé and Danone are facing renewed scrutiny over how they handled the recall of contaminated infant formula, following investigations by public broadcasters in France, Belgium, and Switzerland. The reports allege that Nestlé delayed notifying European authorities about the presence of cereulide, a toxin that can cause vomiting and diarrhea and poses heightened risks for infants. The contamination was linked to an ingredient supplied by China’s CABIO Biotech and used in products from multiple manufacturers, including Nestlé, Danone, and Lactalis. According to the investigation, trace levels of the toxin were detected as early as November, but public recalls were only initiated in January, raising questions about whether affected products remained in distribution channels or households without timely warnings. The reports also suggested that some withdrawals may have been carried out quietly in certain markets before official recalls were issued. $NSRGY $DANOY

0 replies

WallStreetWomper May 4, 9:49 PM

$DANOY Yogurt, my volatility dampener.

0 replies

PickAlpha Feb 18, 6:51 PM

PickAlpha Midday: Nestlé is weighing another step back from ice cream as new CEO Philipp Navratil reviews the portfolio — including potentially trimming its stake in Froneri (the JV housing brands like Häagen-Dazs/Mövenpick) and/or folding remaining wholly-owned local ice cream ops into Froneri. The backdrop is simple: Nestlé stock is near an 8-year low (down ~40% from its 2022 peak), while key peers have meaningfully outperformed — so the market is forcing “simplify + sharpen capital allocation” decisions. Tickers: $NSRGY $UL $DANOY Our view is this is a classic self-help setup: exit/monetize lower-conviction assets to decomplexify and potentially fund deleveraging/buybacks. If Nestlé can show proceeds are real and reallocated into faster-growth/higher-return categories, the “discount to peers” narrative can start to close; if it’s just shuffling minority stakes without a broader margin/growth reset, it won’t move the needle.

0 replies

SenefAS Sep 10, 9:02 PM

Did you have see that all the game player in the food industry buy a microbiome company the last in date it’s Danone : https://www.danone.com/newsroom/press-releases/acquisition-of-the-akkermansia-company.html $MCRB $DANOY $NSRGY $UL

2 replies